Osmolyte Mixture Stabilizes Protein Folding Intermediates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for in vitro protein folding are not universal and often result in protein misfolding and aggregation, necessitating the development of new techniques for stabilizing protein intermediates and optimizing folding conditions.

Innovation Solution

A novel osmolyte composition using high concentrations of urea and glycerol stabilizes partially denatured proteins, allowing GroEL chaperonin to maintain its tetradecameric form and facilitate complete protein folding, while a screening method identifies optimal osmolyte compositions for maximal protein yield and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If high concentrations of urea and glycerol are used to stabilize protein intermediates, then protein aggregation is prevented and folding is enhanced, but the complexity of optimizing folding conditions increases for each specific protein

Engineering Contradiction:
Improveprotein folding stabilityVSAvoidfolding condition optimization
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by systematically varying osmolyte concentrations, pH values, ionic strengths, and temperatures to identify optimal folding conditions for each protein. This involves testing multiple parameter combinations to determine which conditions maximize proper folding while minimizing aggregation, thereby resolving the contradiction between achieving reliable folding and managing optimization complexity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses osmolytes (such as urea and glycerol) as intermediary substances that mediate the folding process by stabilizing protein intermediates. These intermediaries prevent direct aggregation of unfolded proteins while allowing proper folding to occur, thus improving reliability without requiring complex procedural changes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If in vitro folding methods are used to refold aggregated proteins, then protein aggregation is reduced, but the productivity and yield of correctly folded proteins decrease

Engineering Contradiction:
Improveprotein refolding efficiencyVSAvoidprotein yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies preliminary action by adding osmolytes to the refolding buffer before initiating the folding process. This pre-preparation of the folding environment with stabilizing agents ensures that protein intermediates are immediately protected upon dilution, preventing aggregation and enhancing the yield of correctly folded proteins while maintaining refolding efficiency.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses composite refolding buffers containing multiple components including osmolytes, chaperones, and various additives working together. This composite approach combines the stabilizing effects of different substances to simultaneously improve refolding efficiency and increase the overall yield of functional proteins.

Inventive Principle:
Principle #40Composite materials

3Productivity

If bacterial systems are used for protein mass production, then high yields are achieved, but large intracellular aggregates or inclusion bodies form

Engineering Contradiction:
Improveprotein production yieldVSAvoidprotein folding correctness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies the taking out principle by extracting proteins from inclusion bodies through solubilization and then refolding them in vitro using osmolyte-containing buffers. This separates the high-yield production step (where aggregates form) from the folding step (where proper structure is achieved), allowing both high productivity and correct folding to be achieved through a two-stage process.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach prevents large-scale protein misfolding and aggregation, enabling the stabilization of protein intermediates and efficient folding, even in the presence of urea and glycerol, thereby maximizing the production of correctly folded proteins.

Implementation Method 1

A novel osmolyte composition using high concentrations of urea and glycerol stabilizes partially denatured proteins

Methodology Applied
Scientific EffectOsmolyte stabilization:

Implementation Method 2

allowing GroEL chaperonin to maintain its tetradecameric form and facilitate complete protein folding

Methodology Applied
Scientific EffectChaperonin-mediated folding:

Data Source

PatentUS9052323B2Osmolyte mixture for protein stabilization
Publication Date: 2015.06.09 UNIV KANSAS MEDICAL CENT
  • US9052323B2 patent drawing
  • US9052323B2 patent drawing
  • US9052323B2 patent drawing

AI summary

An osmolyte composition comprising 4 M glycerol and 4M urea for stabilizing previously transient protein folding intermediates as long-lived stable forms. A method to search for other possible stabilizing osmolyte mixtures using a screening array is also provided. These additional osmolyte mixtures may complement or augment the successful 4M glycerol/4 M urea mixture.